<bill session="116" type="s" number="4674" updated="2020-10-30T04:26:59Z">
  <state datetime="2020-09-23">REFERRED</state>
  <status>
    <introduced datetime="2020-09-23"/>
  </status>
  <introduced datetime="2020-09-23"/>
  <titles>
    <title type="short" as="introduced">Strengthening Medicaid Coverage of MAT Act</title>
    <title type="short" as="introduced">Strengthening Medicaid Coverage of MAT Act</title>
    <title type="display">Strengthening Medicaid Coverage of MAT Act</title>
    <title type="official" as="introduced">A bill to amend title XIX of the Social Security Act to clarify that drugs and biologicals used for medication-assisted treatment under Medicaid are subject to the requirements of the Medicaid Drug Rebate Program.</title>
  </titles>
  <sponsor bioguide_id="K000367"/>
  <cosponsors>
    <cosponsor bioguide_id="S001203" joined="2020-09-23"/>
  </cosponsors>
  <actions>
    <action datetime="2020-09-23">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-09-23" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="8319"/>
    <bill type="h" session="116" relation="unknown" number="8337"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2020-09-23T04:00:00Z" status="Introduced in Senate">Strengthening Medicaid Coverage of MAT Act

This bill specifically includes in the Medicaid Drug Rebate Program covered outpatient drugs that are used in medication-assisted treatment for opioid-use disorders.</summary>
  <committee-reports/>
</bill>
